BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth
BCA101 是一种针对肿瘤的双功能融合抗体，可同时抑制 EGFR 和 TGFβ 信号传导，从而持久抑制肿瘤生长
期刊:Cancer Research
影响因子:12.5
doi:10.1158/0008-5472.CAN-21-4425
Srinivas Reddy Boreddy, Reshmi Nair, Prashant Kumar Pandey, Anshu Kuriakose, Shivakumar Bhadravathi Marigowda, Chaitali Dey, Arindam Banerjee, Hanumant Kulkarni, Milind Sagar, Shiv Ram Krishn, Shruthi Rao, Madhukara Ar, Vinita Tiwari, Bhavna Alke, Prashantha Kumar Mv, Meena Shri, Chaitrali Dhamne, S
